Clincosm LogoSign in Get a demo

CovPCR: Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Recruiting
CT.gov ID
NCT04738331
Collaborator
(none)
10,000,000
Enrollment
1
Location
16.9
Anticipated Duration (Months)
592169.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Analysing ths spread of COVID-19 epidemics in a timely manner is key to implementing public health control strategies. The investigators propose to analyse a large set of laboratory SARS-CoV-2 RT-PCR data to explore potential links between Ct values and epidemic parameters.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    10000000 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database : CovPCR
    Actual Study Start Date :
    Feb 1, 2021
    Anticipated Primary Completion Date :
    May 20, 2022
    Anticipated Study Completion Date :
    Jun 30, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Detecting co-factors associated with Ct values [1 day]

      Detecting co-factors associated with Ct values

    Secondary Outcome Measures

    1. Detecting associations with epidemic spread [1 day]

      Detecting associations with epidemic spread

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    • A SARS-Cov2 RT-PCR result with a known sampling date
    Exclusion criteria:
    • Patient refusing to participate in research

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Uh Montpellier Montpellier France 34295

    Sponsors and Collaborators

    • University Hospital, Montpellier

    Investigators

    • Study Director: Vincent Foulongne, PhD, UH MONTPELLIER

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Montpellier
    ClinicalTrials.gov Identifier:
    NCT04738331
    Other Study ID Numbers:
    • RECHMPL21_0051
    First Posted:
    Feb 4, 2021
    Last Update Posted:
    May 26, 2021
    Last Verified:
    May 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Montpellier
    SARS-Cov2 infection
    Tested for SARS-Cov2 infection with RT-PCR test
    CT
    epidemiology
    reproduction number
    Additional relevant MeSH terms:
    Infections
    COVID-19
    Severe Acute Respiratory Syndrome

    Study Results

    No Results Posted as of May 26, 2021